Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-02
DOI
10.3389/fonc.2019.00993
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ROS generation and autophagosome accumulation contribute to the DMAMCL-induced inhibition of glioma cell proliferation by regulating the ROS/MAPK signaling pathway and suppressing the Akt/mTOR signaling pathway
- (2019) Yanjun Wang et al. OncoTargets and Therapy
- The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo
- (2019) Ning Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity
- (2018) Ghader babaei et al. BIOMEDICINE & PHARMACOTHERAPY
- Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia
- (2018) Jing Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Metabolic Chemical Reporter 6-Azido-6-deoxy-glucose Further Reveals the Substrate Promiscuity of O-GlcNAc Transferase and Catalyzes the Discovery of Intracellular Protein Modification by O-Glucose
- (2018) Narek Darabedian et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
- (2018) Ming-Chuan Hsu et al. Molecular Cancer
- Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs
- (2018) Clarissa A. Whitehead et al. Translational Oncology
- ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
- (2018) Xiao‐Han Jin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001
- (2018) Xiao-Nan Xi et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Metabolic Profiles in Cell Lines Infected with Classical Swine Fever Virus
- (2017) Hongchao Gou et al. Frontiers in Microbiology
- Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells
- (2016) Qing Ji et al. Oncotarget
- Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis
- (2016) Haiping Zhou et al. Oncotarget
- Pterisolic Acid B is a Nrf2 Activator by Targeting C171 within Keap1-BTB Domain
- (2016) Ting Dong et al. Scientific Reports
- Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation
- (2015) Sophia Y. Lunt et al. MOLECULAR CELL
- Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine
- (2015) Ting Dong et al. Nature Communications
- Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo
- (2015) Yinghong An et al. PLoS One
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects
- (2014) T. T. Batchelor et al. CLINICAL CANCER RESEARCH
- Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery
- (2014) Meghna Talekar et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Activators of PKM2 in cancer metabolism
- (2014) Steven L Warner et al. Future Medicinal Chemistry
- The Warburg effect: molecular aspects and therapeutic possibilities
- (2014) Hanh Ngo et al. MOLECULAR BIOLOGY REPORTS
- Targeting adaptive glioblastoma: an overview of proliferation and invasion
- (2014) Q. Xie et al. NEURO-ONCOLOGY
- Parthenolide: from plant shoots to cancer roots
- (2013) Akram Ghantous et al. DRUG DISCOVERY TODAY
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
- (2013) Joydeep Mukherjee et al. PLoS One
- The Metabolomic Signature of Malignant Glioma Reflects Accelerated Anabolic Metabolism
- (2012) P. Chinnaiyan et al. CANCER RESEARCH
- Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy
- (2012) Charles Kung et al. CHEMISTRY & BIOLOGY
- Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells
- (2012) M. Tamada et al. CLINICAL CANCER RESEARCH
- Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
- (2012) Michael S. Goldberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Guaianolide Sesquiterpene Lactones, a Source To Discover Agents That Selectively Inhibit Acute Myelogenous Leukemia Stem and Progenitor Cells
- (2012) Quan Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biomimetic Semisynthesis of Arglabin from Parthenolide
- (2012) Jia-Dai Zhai et al. JOURNAL OF ORGANIC CHEMISTRY
- Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
- (2012) Dimitrios Anastasiou et al. Nature Chemical Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
- (2011) Q. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells
- (2010) B. Kefas et al. NEURO-ONCOLOGY
- Brain Tumor Stem Cells as Therapeutic Targets in Models of Glioma
- (2010) Dan Richard Laks et al. YONSEI MEDICAL JOURNAL
- Identification of small molecule inhibitors of pyruvate kinase M2
- (2009) Matthew G. Vander Heiden et al. BIOCHEMICAL PHARMACOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started